Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.45%17.03B | 7.32%8.51B | -0.97%16.95B | -6.20%7.93B | -14.44%17.12B | -15.71%8.45B | 8.74%20.01B | 20.19%10.03B | 30.47%18.4B | 37.65%8.34B |
| Operating income | 0.45%17.03B | 7.32%8.51B | -0.97%16.95B | -6.20%7.93B | -14.44%17.12B | -15.71%8.45B | 8.74%20.01B | 20.19%10.03B | 30.47%18.4B | 37.65%8.34B |
| Cost of sales | -2.65%-13.56B | -8.81%-6.63B | -0.73%-13.21B | 5.49%-6.09B | 14.87%-13.11B | 14.51%-6.45B | -14.16%-15.41B | -24.74%-7.54B | -35.17%-13.49B | -37.11%-6.05B |
| Operating expenses | -2.65%-13.56B | -8.81%-6.63B | -0.73%-13.21B | 5.49%-6.09B | 14.87%-13.11B | 14.51%-6.45B | -14.16%-15.41B | -24.74%-7.54B | -35.17%-13.49B | -37.11%-6.05B |
| Gross profit | -7.30%3.47B | 2.38%1.87B | -6.53%3.74B | -8.48%1.83B | -12.98%4B | -19.37%2B | -6.20%4.6B | 8.19%2.48B | 19.08%4.9B | 39.10%2.29B |
| Selling expenses | 1.67%-860.48M | -0.12%-426.46M | -0.78%-875.1M | -1.18%-425.95M | 8.49%-868.35M | 17.66%-420.99M | -0.57%-948.87M | -13.33%-511.29M | -29.35%-943.47M | -53.26%-451.14M |
| Administrative expenses | 11.04%-1.09B | -0.51%-1.12B | 9.94%-1.22B | 8.02%-1.11B | 19.49%-1.35B | 16.26%-1.21B | 4.16%-1.68B | -4.63%-1.45B | -34.84%-1.76B | -54.10%-1.38B |
| Research and development expenses | -14.85%-1.04B | ---- | 15.95%-906.27M | ---- | 12.90%-1.08B | ---- | 0.90%-1.24B | ---- | -34.31%-1.25B | ---- |
| Impairment and provision | -7.77%-309.9M | -23.05%-19.02M | -105.85%-287.56M | -4.43%-15.46M | -56.16%-139.69M | -13.89%-14.8M | 19.94%-89.45M | 13.92%-13M | 43.89%-111.74M | -0.80%-15.1M |
| -Goodwill impairment | ---103.84M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 28.34%-206.06M | -23.05%-19.02M | -105.85%-287.56M | -4.43%-15.46M | -56.16%-139.69M | -13.89%-14.8M | 19.94%-89.45M | 13.92%-13M | 36.97%-111.74M | -0.80%-15.1M |
| Special items of operating profit | 19.52%348.42M | -16.07%99.84M | -22.21%291.52M | 68.73%118.95M | 24.13%374.77M | -53.08%70.5M | -40.52%301.92M | -14.16%150.26M | 122.14%507.58M | 96.24%175.05M |
| Operating profit | -30.07%520.32M | 3.69%410.28M | -20.58%744.01M | -7.00%395.67M | -0.67%936.78M | -35.76%425.46M | -30.23%943.09M | 6.64%662.32M | 13.94%1.35B | 16.66%621.1M |
| Financing cost | 32.10%-119.45M | 38.57%-61.33M | 13.27%-175.92M | -20.16%-99.84M | -79.16%-202.83M | -60.19%-83.09M | -13.72%-113.21M | -15.38%-51.87M | 34.27%-99.56M | 50.15%-44.96M |
| Earning before tax | -29.44%400.87M | 17.95%348.95M | -22.60%568.1M | -13.59%295.83M | -11.56%733.95M | -43.91%342.37M | -33.72%829.88M | 5.96%610.45M | 20.99%1.25B | 30.29%576.14M |
| Tax | -35.84%-77.36M | -223.59%-33.92M | -167.63%-56.95M | -226.06%-10.48M | 70.05%-21.28M | 121.01%8.31M | 38.42%-71.05M | 33.09%-39.57M | -33.04%-115.39M | -31.12%-59.15M |
| After-tax profit from continuing operations | -36.71%323.51M | 10.40%315.03M | -28.28%511.15M | -18.63%285.35M | -6.08%712.67M | -38.57%350.69M | -33.24%758.83M | 10.42%570.88M | 19.89%1.14B | 30.19%517M |
| Earning after tax | -36.71%323.51M | 10.40%315.03M | -28.28%511.15M | -18.63%285.35M | -6.08%712.67M | -38.57%350.69M | -33.24%758.83M | 10.42%570.88M | 19.89%1.14B | 30.19%517M |
| Minority profit | 215.79%2.06M | -44.96%-532K | -144.84%-1.78M | -7.62%-367K | -18.79%-727K | 49.41%-341K | -176.92%-612K | 7.16%-674K | 96.76%-221K | 83.01%-726K |
| Profit attributable to shareholders | -37.33%321.45M | 10.44%315.56M | -28.10%512.93M | -18.60%285.72M | -6.06%713.39M | -38.58%351.03M | -33.20%759.44M | 10.40%571.55M | 19.06%1.14B | 28.99%517.72M |
| Basic earnings per share | -35.83%0.1284 | 15.65%0.1264 | -22.68%0.2001 | -12.14%0.1093 | -0.88%0.2588 | -36.60%0.1244 | -36.15%0.2611 | 3.70%0.1962 | 8.00%0.4089 | 16.65%0.1892 |
| Diluted earnings per share | -36.45%0.1222 | 14.11%0.1205 | -23.26%0.1923 | -12.58%0.1056 | -0.48%0.2506 | -35.40%0.1208 | -34.43%0.2518 | 5.23%0.187 | 7.59%0.384 | 12.97%0.1777 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.